Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06738992 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study compares the efficacy and safety of two different antithrombotic drugs, warfarin and aspirin, in early application after mitral valve repair (MVRep). The objective is to verify whether the type of antithrombotic therapy affects clinical outcomes and the incidence of thromboembolic and bleeding complications within 3 months after MVRep, and to provide safe and effective antithrombotic treatment options for patients undergoing MVRep.
Trial Details
NCT Number NCT06738992
Lead Sponsor Guangdong Provincial People's Hospital
Conditions
(from sponsor)		 Mitral Valve Repair Surgery
Enrollment 384 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov